Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Puerarin Supplementation for CVD Risk Factors in Men
NCT03676296Phase 2Completed
- Sponsor
- The University of Hong Kong
- Start
- Sep 2018
- Primary completion
- Apr 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of puerarin in cardiovascular disease (CVD), dyslipidemia, sponsored by The University of Hong Kong. Started Sep 2018; status: completed.
02
Drugs
puerarin
03
Conditions
cardiovascular disease (CVD)dyslipidemia
Beyond the preview
Go deeper on NCT03676296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03676296.